Trimebutine Maleate in the Treatment of Irritable Bowel Syndrome: Canadian Clinical Experience
An open multicentre study was conducted at 18 Canadian centres in patients diagnosed as suffering from irritable bowel syndrome ((BS). One hundred and thirty-one (72%, female and 28% male) patients, mean age 44 years, were treated with 200 mg tid trimebutine maleate (Modulon; Jouveinal) for periods...
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Wiley
1987-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/1987/813961 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|